- Home
- BWLP vs ZLAB Comparison
BWLP vs ZLAB Comparison
Compare BWLP & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWLP
- ZLAB
- Stock Information
- Founded
- BWLP 1935
- ZLAB 2013
- Country
- BWLP Singapore
- ZLAB China
- Employees
- BWLP N/A
- ZLAB N/A
- Industry
- BWLP Marine Transportation
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- BWLP Consumer Discretionary
- ZLAB Health Care
- Exchange
- BWLP Nasdaq
- ZLAB Nasdaq
- Market Cap
- BWLP 1.6B
- ZLAB 3.6B
- IPO Year
- BWLP N/A
- ZLAB 2017
- Fundamental
- Price
- BWLP $12.60
- ZLAB $35.20
- Analyst Decision
- BWLP
- ZLAB Buy
- Analyst Count
- BWLP 0
- ZLAB 5
- Target Price
- BWLP N/A
- ZLAB $54.28
- AVG Volume (30 Days)
- BWLP 423.8K
- ZLAB 839.0K
- Earning Date
- BWLP 08-27-2025
- ZLAB 08-05-2025
- Dividend Yield
- BWLP 13.33%
- ZLAB N/A
- EPS Growth
- BWLP N/A
- ZLAB N/A
- EPS
- BWLP 1.86
- ZLAB N/A
- Revenue
- BWLP $3,387,328,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- BWLP N/A
- ZLAB $44.07
- Revenue Next Year
- BWLP $2.04
- ZLAB $49.13
- P/E Ratio
- BWLP $7.41
- ZLAB N/A
- Revenue Growth
- BWLP 9.53
- ZLAB 43.72
- 52 Week Low
- BWLP $7.86
- ZLAB $16.01
- 52 Week High
- BWLP $18.87
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- BWLP 65.22
- ZLAB 48.55
- Support Level
- BWLP $11.58
- ZLAB $34.26
- Resistance Level
- BWLP $12.82
- ZLAB $36.97
- Average True Range (ATR)
- BWLP 0.27
- ZLAB 1.10
- MACD
- BWLP 0.04
- ZLAB -0.41
- Stochastic Oscillator
- BWLP 82.26
- ZLAB 23.98
About BWLP BW LPG Limited Common Shares
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.